Mapping the Diagnostics Landscape
A UKADC Workshop for System Partners

April 3rd 2019, The Wellcome Collection, London

Overview

This workshop, part of a series ran by the UKADC, has been facilitated to support the governments ambition to embed point of care diagnostics in clinical decision making as part of the UK response to the global challenge of AMR. The UK’s AMR five year national action plan 2019-2024, highlights that any effort to tackle AMR must include a focus on improving the development of, and access to, good quality old and new antimicrobials, vaccines diagnostics and infection prevention and control products, as well as promoting alternatives to antibiotics.

This workshop, the 3rd in a series, will articulate the roles of key system partners in the innovation and adoption landscape, to ensure there is a greater understanding of the challenges and awareness of potential solutions relating to the development, evaluation and deployment of point of care diagnostics in response to the AMR challenge. Diagnostics are the signalling system of the NHS and point of care diagnostics have a significant role to play in the reduction of antibiotic prescribing. The UK AMR Diagnostic Collaborative (UK ADC), on behalf of NHS England, wants to enable the health system[1] and industry partners to achieve greater transparency pathways from idea generation to adoption

[1] Regulatory environment, policy innovation, funding, quality, safety and research

Why attend?

The UK AMR diagnostic collaborative has undertaken a series of engagement events to gain an understanding from industry and industry representatives on:

·        The current challenges when accelerating usage of solutions manufactured by industry

·        The challenges and potential solutions to feed into national policy

·        Highlight opportunities for test bed working

The culmination in the series of events is to meet with system partners to understand:

  • How can health system partners in regulation, policy innovation, funding, quality, safety and research support the governments ambition to embed rapid diagnostics in clinical decision making as part of the UK response to the global challenge of AMR?

  • What does the current system looks like?

  • Is the current system fit for purpose?

  • Have system providers got enough support?

*Please note this workshop is strictly for those professionals involved within the system of Rapid Diagnostic Policy and Regulation. This event is also not in conjunction with Antibiotic Guardian

AGENDA

Supported by:

08:45 - 09:25 - Delegate Registration & Refreshments

09:25 - 09:30 - Introduction to the day, aims, ambitions and what we want to achieve

09.30-09.45- Keynote address- Lord O’Neill of Gatley, Author of the O’Neill Review into Antibiotic Resistance

09:45 - 10:35 - Panel session: Biological test should be mandatory, should’nt they?

Meeting the Lord O’Neill Challenge ‘“High-income countries should make it mandatory that by 2020 the prescription of antibiotics will need to be informed by data and testing technology wherever it is available”. This panel session will explore if there actually is a role for Diagnostics in supporting primary care decision making and if so why are we not using them?

Panel-

  • Phil Howard, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals

  • Mark Fielder, Professor of Medical Microbiology, Kingston University, London

  • David Wells, Head of Pathology Services Consolidation, NHS Improvement

  • Dr Elisabeth Adams, MD, Aquarius Population Health

10:35 - 11:35 - Mapping the current landscape and system for Diagnostics

This session will explore, through a facilitated workshop, the current system for diagnostics, who does what, why and how? We will explore attendees roles in this system, understanding their influence within the acceleration of diagnostic usage and find out if it is working or not?

Session supported by Dr Sarah Byron,Associate Director,Diagnostics Assessment Programme, National Institute for Health and Care Excellence & Scott Buckler, Founder, 4 All of Us

11:35 - 11:50 - How a diagnostic pathway can be achieved

Mike Wakemen, Pharmacist Consultant, will discuss how he has driven community diagnostic usage within England and how he achieved it

11:50 - 12:00 - How industry are driving Diagnostic usage

Greg Quinn, Director, Public Policy & Advocacy UKI,Corporate/Shared Services, BD

12:00 -12:30 - Lunch & networking

12:30 - 12:50 - The role of Health Technology Assessment for Diagnostics

Dr Sarah Byron,Associate Director,Diagnostics Assessment Programme, National Institute for Health and Care Excellence

12:50 - 13:15 - What the Landscape for Diagnostics is telling us

This session will reflect on the previous UKADC meetings for Clinicians & Industry as well as reflecting on the morning session on the system as seen from the attendees

13:15 - 14:00 - Identifiying the roadblocks to diagnostic acceleration and the opportunities the system can cease

This session, chaired by Daniel Berman, Lead of Global Health Team, Nesta, will identify current roadblocks to the promotion and usage of diagnostics. Daniel, via a audience Q&A, will challenge current thinking and explore how the system can be more effective whilst supporting health professionals

14:00 -14:10 - Close